CENTRAL NEURO SERVICES LIMITED

Company Registration Number:
NI651404 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 October 2025

Period of accounts

Start date: 01 November 2024

End date: 31 October 2025

CENTRAL NEURO SERVICES LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2025

Balance sheet
Notes

CENTRAL NEURO SERVICES LIMITED

Balance sheet

As at 31 October 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 74,750 1,000
Total fixed assets: 74,750 1,000
Current assets
Debtors:   1,311,918 0
Cash at bank and in hand: 666,543 1,968,516
Total current assets: 1,978,461 1,968,516
Creditors: amounts falling due within one year:   (36,113) (48,895)
Net current assets (liabilities): 1,942,348 1,919,621
Total assets less current liabilities: 2,017,098 1,920,621
Total net assets (liabilities): 2,017,098 1,920,621
Capital and reserves
Called up share capital: 101 101
Profit and loss account: 2,016,997 1,920,520
Shareholders funds: 2,017,098 1,920,621

The notes form part of these financial statements

CENTRAL NEURO SERVICES LIMITED

Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 07 September 2026
and signed on behalf of the board by:

Name: S Haffey
Status: Director

The notes form part of these financial statements

CENTRAL NEURO SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

CENTRAL NEURO SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

2. Employees

2025 2024
Average number of employees during the period 1 1

CENTRAL NEURO SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2025

3. Tangible Assets

Total
Cost £
At 01 November 2024 3,000
Additions 99,000
At 31 October 2025 102,000
Depreciation
At 01 November 2024 2,000
Charge for year 25,250
At 31 October 2025 27,250
Net book value
At 31 October 2025 74,750
At 31 October 2024 1,000